{"id":"W4306353000","doi":"10.1038/s41467-022-33867-9","title":"The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial","year":2022,"lang":"en","type":"article","venue":"Nature Communications","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Banting and Best Diabetes Centre, University of Toronto; Canadian Institutes of Health Research; University of Toronto; Government of Canada","keywords":"Exenatide; Medicine; Insulin glargine; Insulin lispro; Internal medicine; Type 2 diabetes; Glycemic; Lixisenatide; Endocrinology; Randomized controlled trial; Insulin; Population; Liraglutide; Glucagon-like peptide 1 receptor; Diabetes mellitus; Agonist; Receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006326901,0.002087405,0.003991609,0.0006223559,0.0006310834,0.001611039,0.001141638,0.002435569,0.004533555],"category_scores_gemma":[0.004702912,0.001065363,0.002552365,0.0005656885,0.001637884,0.001562318,0.000671567,0.003321755,0.0006807983],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000671092,"about_ca_system_score_gemma":0.001598605,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005589909,"about_ca_topic_score_gemma":0.001161179,"domain_scores_codex":[0.9964552,0.002476063,0.0002394218,0.0003822641,0.0001302622,0.0003167141],"domain_scores_gemma":[0.9970545,0.001075655,0.0005363187,0.0003216548,0.0001640235,0.0008479184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9931038,0.003248726,0.0001898549,0.00007502104,0.0001799191,0.00001028257,0.00001564221,0.000073895,0.0005537997,0.00001876211,0.00005193162,0.002478366],"study_design_scores_gemma":[0.9400294,0.05832529,0.0007420187,0.00001233855,0.0002699605,0.00001043011,0.00001027551,0.000264262,0.0001728962,0.00005924027,0.00009623947,0.000007628652],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897975,0.001757075,0.0006984539,0.0004459186,0.0004949194,0.005278932,0.0003654994,0.00008507705,0.001076716],"genre_scores_gemma":[0.9864082,0.001077542,0.002490432,0.0006846291,0.0004830585,0.006919057,0.0005825075,0.0000200322,0.001334562],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006326901,"threshold_uncertainty_score":0.03346026,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02602615347631074,"score_gpt":0.3479655666161127,"score_spread":0.321939413139802,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}